1. Home
  2. MUX vs NRIX Comparison

MUX vs NRIX Comparison

Compare MUX & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$24.11

Market Cap

1.6B

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.47

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
NRIX
Founded
1979
2009
Country
Canada
United States
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MUX
NRIX
Price
$24.11
$16.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$26.63
$30.50
AVG Volume (30 Days)
913.5K
1.2M
Earning Date
05-06-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$37.86
N/A
Revenue Next Year
$31.10
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
99.31
52 Week Low
$7.15
$8.20
52 Week High
$29.70
$22.50

Technical Indicators

Market Signals
Indicator
MUX
NRIX
Relative Strength Index (RSI) 54.83 52.99
Support Level $22.96 $15.62
Resistance Level $24.88 $16.71
Average True Range (ATR) 1.18 0.88
MACD 0.50 0.14
Stochastic Oscillator 62.88 52.24

Price Performance

Historical Comparison
MUX
NRIX

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: